Skip to main content

Table 2 Renal dysfunction or failure and mean values of renal function assessment parameters among patients with and without Tenofovir Disoproxil Fumarate containing ART regimen

From: The effect of Tenofovir on renal function among Ugandan adults on long-term antiretroviral therapy: a cross-sectional enrolment analysis

Renal function assessment parameter

All participants

n (%)

TDF exposure

P value*

 

Non-TDF ART n (%)

TDF ART n (%)

 

All

953

385 (40.4)

568 (59.6)

 

eGFR (Cockcroft-Gault, adj for BSA), mean (SD)

108.6 (37.0)

110.0 (36.0)

107.3 (36.8)

0.197

 Normal

901 (97.0)

371 (97.6)

530 (96.5)

0.338

 Renal dysfunction/failure

28 (3.0)

9 (2.4)

19 (3.5)

 

eGFR (Cockcroft-Gault, without BSA adj), mean (SD)

104.9 (68.4)

103.6 (58.9)

104.6 (71.3)

0.933

 Normal

874 (93.9)

363 (95.3)

511 (92.9)

0.139

 Renal dysfunction/failure

57 (6.1)

18 (4.7)

39 (7.1)

 

eGFR (CKD-Epi), mean (SD)

102.9 (18.0)

105.3 (17.5)

101.7 (18.2)

0.001

 Normal

929 (98.1)

378 (98.2)

551 (98.0)

0.878

 Renal dysfunction/failure

18 (1.9)

7 (1.8)

11 (2.0)

 

eGFR (MDRD with race), mean(SD)

131.7 (43.8)

135.9 (47.0)

128.9 (40.2)

0.008

 Normal

935 (98.7)

382 (99.2)

553 (98.4)

0.267

 Renal dysfunction/failure

12 (1.3)

3 (0.8)

9 (1.6)

 

Fractional Tubular PO4 reabsorption %, mean (SD)

92.1 (6.1)

92.7 (5.7)

91.7 (6.3)

0.047

 Normal

734 (95.7)

325 (95.3)

409 (96.0)

0.634

 Abnormal Fractional Tubular PO4 reabsorption

33 (4.3)

16 (4.7)

17 (4.0)

 

Proteinuria on dipstick (mg/dl)

    

 Negative

646 (69.5)

298 (78.6)

348 (63.2)

<0.001

 Trace (1–30)

120 (12.9)

38 (10.0)

82 (14.9)

 

 Positive (30+)

164 (17.6)

43 (11.3)

121 (22.0)

 

Serum urea (mmol/L), mean (SD)

3.1 (1.3)

3.0 (1.2)

3.2 (1.4)

0.001

 Desirable

944 (99.8)

384 (100.0)

560 (99.6)

0.242

 Abnormal (>11.9)

2 (0.2)

0 (0.0)

2 (0.4)

 

Serum creatinine (µmol/L), mean (SD)

65.5 (20.3)

64.0 (18.5)

66.8 (20.8)

0.023

 Desirable

930 (98.2)

381 (99.0)

549 (97.7)

0.147

 Abnormal (>109)

17 (1.8)

4 (1.0)

13 (2.3)

 

Serum phosphates (mmol/L), mean (SD)

1.0 (0.3)

1.0 (0.2)

1.1 (0.3)

0.023

 Hypophosphataemia (<0.81)

122 (13.1)

64 (16.6)

58 (10.6)

0.012

 Normal (0.81–1.5)

799 (85.5)

318 (82.6)

481 (87.6)

 

 Hyperphosphataemia (>1.5)

13 (1.4)

3 (0.8)

10 (1.8)

 
  1. BSA adj body surface area adjustment
  2. * P value showing evidence for mean differences in estimated parameters by TDF exposure (in italics) and Chi-square test P value (not in italics). Renal dysfunction/failure defined as eGFR: <60 ml/min/1.73 m2. Some missing eGFR values due to missing some anthropometric measures used to calculate eGFR e.g. patients who could not stand upright because of being lame